Accelerate Diagnostics EBIT 2010-2024 | AXDXQ

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accelerate Diagnostics ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accelerate Diagnostics ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$174B
Intuitive Surgical (ISRG)	$168.5B
IDEXX Laboratories (IDXX)	$52.6B
Edwards Lifesciences (EW)	$46B
Alcon (ALC)	$42.3B
DexCom (DXCM)	$30.9B
IQVIA Holdings (IQV)	$30.6B
Mettler-Toledo (MTD)	$25.9B
STERIS (STE)	$23.9B
Waters (WAT)	$16.7B
SONOVA HOLDING (SONVY)	$16.6B
Hologic (HOLX)	$15.1B
Penumbra (PEN)	$9.4B
Sysmex ADR (SSMXY)	$8.7B
Globus Medical (GMED)	$7.9B
Masimo (MASI)	$7.9B
Teleflex (TFX)	$5.2B
Glaukos (GKOS)	$4.9B
TransMedics (TMDX)	$3.9B
Integer Holdings (ITGR)	$3.7B
LivaNova (LIVN)	$2.7B
Alphatec Holdings (ATEC)	$2.2B
Veracyte (VCYT)	$2.2B
PROCEPT BioRobotics (PRCT)	$2.1B
Nihon Kohden (NHNKY)	$2B
Elekta AB (EKTAY)	$1.9B
Artivion (AORT)	$1.7B
Paragon 28 (FNA)	$1.1B
Integra LifeSciences Holdings (IART)	$1B
OPKO Health (OPK)	$992M